These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 14694520)

  • 1. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).
    García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
    Cancer Invest; 2008; 26(3):222-9. PubMed ID: 18317962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
    Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
    Hui W; Bell M; Carroll G
    Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
    Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
    Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo.
    Weiss TW; Simak R; Kaun C; Rega G; Pflüger H; Maurer G; Huber K; Wojta J
    Anticancer Res; 2011 Oct; 31(10):3273-8. PubMed ID: 21965736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
    Okamoto M; Lee C; Oyasu R
    Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
    Mori S; Murakami-Mori K; Bonavida B
    Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
    Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and effects of gp130 cytokines and receptors in prostate cancer cells.
    Palmer J; Hertzog PJ; Hammacher A
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2258-69. PubMed ID: 15313471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
    Savarese TM; Campbell CL; McQuain C; Mitchell K; Guardiani R; Quesenberry PJ; Nelson BE
    Cytokine; 2002 Mar; 17(6):324-34. PubMed ID: 12061840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis.
    Stürzl M; Brandstetter H; Zietz C; Eisenburg B; Raivich G; Gearing DP; Brockmeyer NH; Hofschneider PH
    Oncogene; 1995 May; 10(10):2007-16. PubMed ID: 7761101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.